Home >NHS Blood and Transplant appoints new Blood Manufacturing and Logistics Director

NHS Blood and Transplant appoints new Blood Manufacturing and Logistics Director

22 October 2015

Peter Lidstone has been appointed as Director of Blood Manufacturing and Logistics at NHS Blood and Transplant. He will take up the post on 2 November.

Mr Lidstone has extensive experience in manufacturing and logistics in the fine chemicals, food and coatings industries. He has led transformational projects and continuous improvement programmes to drive safety, service, quality, costs and engagement towards world class levels.

He will lead blood and blood component manufacturing in five centres across England and operate a 24/7 logistics fleet delivering routine and emergency blood products to hospitals. He will be responsible for 850 manufacturing and 350 logistics employees.

Mr Lidstone said, "I am looking forward to working with the manufacturing and logistics team to continue the journey towards operational excellence and to ensure that, across NHS Blood and Transplant, the operations are ready for new opportunities as they arise in the coming years. Delivering excellent customer and consumer service is always a key goal for a supply chain and I am very excited about working in such a life-saving environment where delivery takes on a very different perspective”.

Welcoming the appointment NHS Blood and Transplant Chief Executive, Ian Trenholm, said: "I am delighted to welcome Peter to this very important role ensuring patients get the blood and related products they need for life saving or improving treatment. We are already one of the most productive blood manufacturers in the world and I look forward to working with Peter to continue to deliver a safe supply as efficiently as possible to the benefit of the NHS.”

NHS Blood and Transplant is crucial to the NHS delivering blood and blood based therapies across England and north Wales; organ donation and supply services for the whole of the UK; retrieval and storage of other tissues like skin and bone and a range of specialist therapeutic blood products and related services.